Divi's Laboratories Ltd. announcements
In the twelve months since 23 September 2025 Divi's Laboratories Ltd. made 47 announcements to NSE under Regulation 30: 12 analysts/institutional investor meet/con. call updates, 11 copy of newspaper publication, 5 outcome of board meeting, 4 certificate under sebi (depositories and participants) regulations, 2018, 4 trading window, 2 shareholders meeting. The latest, on 12 September 2026, was filed under copy of newspaper publication; the table carries the company's own summary of each and the PDF.
| Date | Category | What the company told the exchange | Filing |
|---|---|---|---|
| 12 September 2026 | Copy of Newspaper Publication | Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication | |
| 10 August 2026 | Shareholders meeting | Divi's Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 10, 2026. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results. | |
| 6 August 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Divi's Laboratories Limited has informed the Exchange about Transcript | |
| 3 August 2026 | Copy of Newspaper Publication | Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication | |
| 1 August 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Divi's Laboratories Limited has informed the Exchange about Link of Recording | |
| 1 August 2026 | Change in Management | Divi's Laboratories Limited has informed the Exchange about change in Senior Management. | |
| 1 August 2026 | Outcome of Board Meeting | Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026. | |
| 31 July 2026 | Retirement | Divi's Laboratories Limited has informed the Exchange about Retirement of Senior Management Personnel. | |
| 24 July 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Divi's Laboratories Limited has informed the Exchange about Schedule of meet | |
| 17 July 2026 | Copy of Newspaper Publication | Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication | |
| 15 July 2026 | Shareholders meeting | Divi's Laboratories Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 10, 2026 | |
| 13 July 2026 | Copy of Newspaper Publication | Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication regarding Notice of 36th Annual General Meeting, Record date for dividend and other information | |
| 7 July 2026 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | Divi's Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | |
| 6 July 2026 | Disclosure under SEBI Takeover Regulations | Divi's Laboratories Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. | |
| 30 June 2026 | Trading Window | Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | |
| 11 June 2026 | Updates | Divi's Laboratories Limited has informed the Exchange regarding 'Information regarding deduction of Income tax at source from payment of Dividend for the financial year 2025-26'. | |
| 4 June 2026 | Copy of Newspaper Publication | Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication - Notice to the shareholders regarding transfer of unclaimed dividend(s) and equity shares to Investor Education and Protection Fund (IEPF) | |
| 29 May 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Divi's Laboratories Limited has informed the Exchange about Transcript | |
| 25 May 2026 | Copy of Newspaper Publication | Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication | |
| 25 May 2026 | Outcome of Board Meeting | Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. | |
| 23 May 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Divi's Laboratories Limited has informed the Exchange about link of Q4FY2026 earnings call audio recording. | |
| 23 May 2026 | Record Date | Divi's Laboratories Limited has informed the Exchange that Record date for the purpose of Dividend is 24-Jul-2026. | |
| 23 May 2026 | Dividend | Divi's Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on May 23, 2026, recommended Final Dividend of Rs. 30 per equity share. | |
| 23 May 2026 | Outcome of Board Meeting | Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. | |
| 15 May 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Divi's Laboratories Limited has informed the Exchange about Schedule of earnings conference call. | |
| 15 May 2026 | Copy of Newspaper Publication | Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication | |
| 6 April 2026 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | Divi's Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | |
| 31 March 2026 | Trading Window | Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | |
| 21 March 2026 | Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company | Divi's Laboratories Limited has informed the Exchange about Draft Order issued under Section 144C(1) of the Income Tax Act, 1961 for FY2022-23. | |
| 14 March 2026 | Copy of Newspaper Publication | Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication | |
| 14 February 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Divi's Laboratories Limited has informed the Exchange about Transcript | |
| 12 February 2026 | Copy of Newspaper Publication | Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication | |
| 11 February 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Divi's Laboratories Limited has informed the Exchange about Link of Recording | |
| 11 February 2026 | Outcome of Board Meeting | Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025. | |
| 3 February 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Divi's Laboratories Limited has informed the Exchange about Schedule of meet | |
| 3 January 2026 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | Divi's Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | |
| 31 December 2025 | Trading Window | Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | |
| 14 November 2025 | General Updates | Divi's Laboratories Limited has informed the Exchange about US-FDA Inspection of Company s Unit-I manufacturing facility | |
| 12 November 2025 | Analysts/Institutional Investor Meet/Con. Call Updates | Divi's Laboratories Limited has informed the Exchange about Transcript | |
| 8 November 2025 | Copy of Newspaper Publication | Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication | |
| 7 November 2025 | Analysts/Institutional Investor Meet/Con. Call Updates | Divi's Laboratories Limited has informed the Exchange about Link of Recording | |
| 7 November 2025 | Appointment | Divi's Laboratories Limited has informed the Exchange regarding Appointment of Mr Nimmagadda Venkata Anirudh as President (Nutraceuticals) and Senior Management Personnel of the company w.e.f. November 07, 2025. | |
| 7 November 2025 | Outcome of Board Meeting | Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025. | |
| 29 October 2025 | Analysts/Institutional Investor Meet/Con. Call Updates | Divi's Laboratories Limited has informed the Exchange about Schedule of Q2FY2026 earnings conference call. | |
| 14 October 2025 | Copy of Newspaper Publication | Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication | |
| 7 October 2025 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | Divi's Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | |
| 30 September 2025 | Trading Window | Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
Regulation 30 of SEBI's listing regulations requires a company to tell the exchange of material events; the category is the exchange's, the words are the company's own summary as filed, cut to a few lines, and the PDF is the full filing.
Source
Corporate announcements on nseindia.com for DIVISLAB.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.